Results 141 to 150 of about 1,721,302 (204)

Characterization and Clinical Diagnostic Potential of IHRDEGs in Renal Interstitial Fibrosis: An Integrative Data Analysis and Model Construction Study. [PDF]

J Inflamm Res
Zhang J, Dang X, Dai E.
europepmc   +1 more source

Nucleic Acid Therapeutics for "Undruggable" Cancer Targets: Mechanisms, Challenges, and Prospects. [PDF]

Adv Sci (Weinh)
Xu F, Wang K, Lu K, Hou T, Chen Y, Wang X, Jin H.   +6 more
europepmc   +1 more source

A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical association. [PDF]

Transl Oncol
Elgehama AM, Yang Q, Pires Sanches JG, He Z, Ruegg L, You S, Yang W.   +6 more
europepmc   +1 more source

Synergistic Antitumor Activity of HAT Inhibitor A485 and XPO1 Inhibitor KPT8602 in Multiple Myeloma. [PDF]

Cancer Med
Xu H, Wu W, Jiang Y, Wang J, Zhai Y, Zhao Z.   +5 more
europepmc   +1 more source

<i>Mycn</i> Reactivates the Cell Cycle in Adult Cardiomyocytes and Promotes Cardioprotection in Myocardial Infarction. [PDF]

J Am Heart Assoc
Hirofuji A, Tanaka H, Tsujita Y, Okubo R, Ushioda R, Fujii Y, Ono Y, Hashimoto M, Kanao-Kanda M, Mizukami Y, Kamiya H, Oyama K.   +11 more
europepmc   +1 more source

Epigenetics as a mechanism of lineage extinction and relapse of B-cell lymphoma treated with CD19 CAR T-cell therapy. [PDF]

Blood Neoplasia
Torabi A, Love J, Wu D, Hirayama A, Naresh K.   +4 more
europepmc   +1 more source

MYC-bound enhancer RNAs in cis regulate gene transcription and tumorigenesis. [PDF]

Sci Adv
Li S, Wang Z, Nguyen P, Wang Y, Zhao Y, Wang Y, Chen Y, Huang H, Wang X, Zhang Y, Huang Y, Pattarayan D, Zhang M, Liu Y, Li S, Yang D.   +15 more
europepmc   +1 more source

Omacetaxine reduces c-Myc expression and demonstrates antitumor effects in osteosarcoma. [PDF]

Sci Rep
Farrell KB, Das S, Thamm DH.
europepmc   +1 more source

<i>PLAG1</i> rearrangement may be an oncogenic driver in a subset of sporadic cardiac myxomas: a case-control study. [PDF]

Front Cardiovasc Med
Maffini F, Lepanto D, Pisa E, De Camilli E, Catto V, Zanetti C, Pessina S, Carbucicchio C, Pagni F, Fusco N.   +9 more
europepmc   +1 more source

Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein-protein interaction in inv(16) AML: from fusion biology to targeted therapy. [PDF]

Discov Oncol
Kamel EM, Khadrawy SM, Ali MAM, Ahmed NA, Alkhedhairi S, Alkhayl FFA, Lamsabhi AM.   +6 more
europepmc   +1 more source